Dying endothelial cells stimulate proliferation of malignant glioma cells via a caspase 3‑mediated pathway

Mao,Ping; Smith,Luke; Xie,Wanfu; Wang,Maode

doi:10.3892/ol.2013.1223

Dying endothelial cells stimulate proliferation of malignant glioma cells via a caspase 3‑mediated pathway

Authors:
- Ping Mao
- Luke Smith
- Wanfu Xie
- Maode Wang
View Affiliations

Affiliations: Department of Neurosurgery, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Neurological Surgery, The Ohio State University Medical Center, Columbus, OH 43210, USA
Published online on: March 1, 2013 https://doi.org/10.3892/ol.2013.1223
Pages: 1615-1620

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Emerging evidence has indicated that apoptotic cells have a compensatory effect on the proliferation of neighboring cells. However, the potential role of dying vascular endothelial cells (ECs) in glioma tumor proliferation remains unclear. In the present study, three glioma cell lines were cocultured with dying ECs under various conditions to evaluate the effect of dying ECs on tumor proliferation using alamarBlue and trypan blue assays to assess cell proliferation and viability, respectively. The results suggested that dying ECs had a marked ability to facilitate glioma cell growth via a caspase 3‑mediated pathway. Furthermore, calcium‑independent phospholipase A2 (iPLA2), a downstream gene regulated by caspase 3, is highly involved in this process. Prostaglandin E2 (PGE2) was the final effector of the caspase 3‑iPLA2 signaling pathway in glioma cell proliferation. Knockdown of caspase 3 or iPLA2 using shRNA negated the growth stimulating effect of dying ECs. By contrast, the overexpression of iPLA2 in ECs via the pLEX lentiviral vector system or addition of PGE2 into culture medium had a growth promoting effect on glioma cells. Overall, the present data revealed a paracrine signal released from dying ECs which promotes the proliferation of surrounding glioma cells, demonstrating the importance of blocking compensatory proliferation during tumor therapy. Additionally, targeting caspase 3‑mediated pathways combined with current therapeutic strategies may be a promising approach for improving the dismal prognosis associated with these malignant tumors.

View Figures

View References

1	Franses JW and Edelman ER: The evolution of endothelial regulatory paradigms in cancer biology and vascular repair. Cancer Res. 71:7339–7344. 2011. View Article : Google Scholar : PubMed/NCBI
2	Calabrese C, Poppleton H, Kocak M, et al: A perivascular niche for brain tumor stem cells. Cancer Cell. 11:69–82. 2007. View Article : Google Scholar : PubMed/NCBI
3	Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
4	Carmeliet P and Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature. 473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
5	Sakurai T and Kudo M: Signaling pathways governing tumor angiogenesis. Oncology. 81(Suppl 1): 24–29. 2011. View Article : Google Scholar
6	Ribatti D: Cancer stem cells and tumor angiogenesis. Cancer Lett. 321:13–17. 2012. View Article : Google Scholar : PubMed/NCBI
7	Garcia-Barros M, Paris F, Cordon-Cardo C, et al: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 300:1155–1159. 2003. View Article : Google Scholar : PubMed/NCBI
8	Li F, Huang Q, Chen J, et al: Apoptotic cells activate the ‘phoenix rising’ pathway to promote wound healing and tissue regeneration. Sci Signal. 3:ra132010.
9	Zhao X, Wang D, Zhao Z, et al: Caspase-3-dependent activation of calcium-independent phospholipase A₂ enhances cell migration in non-apoptotic ovarian cancer cells. J Biol Chem. 281:29357–29368. 2006. View Article : Google Scholar : PubMed/NCBI
10	Lauber K, Bohn E, Kröber SM, et al: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 113:717–730. 2003. View Article : Google Scholar : PubMed/NCBI
11	Cohen D, Papillon J, Aoudjit L, Li H, Cybulsky AV and Takano T: Role of calcium-independent phospholipase A₂ in complement-mediated glomerular epithelial cell injury. Am J Physiol Renal Physiol. 294:F469–F479. 2008. View Article : Google Scholar : PubMed/NCBI
12	Böhm I and Schild H: Apoptosis: the complex scenario for a silent cell death. Mol Imaging Biol. 5:2–14. 2003.
13	Bär PR: Apoptosis - the cell’s silent exit. Life Sci. 59:369–378. 1996.
14	Chera S, Ghila L, Dobretz K, et al: Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration. Dev Cell. 17:279–289. 2009.PubMed/NCBI
15	Fan Y and Bergmann A: Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye. Dev Cell. 14:399–410. 2008. View Article : Google Scholar : PubMed/NCBI
16	Hwang JS, Kobayashi C, Agata K, Ikeo K and Gojobori T: Detection of apoptosis during planarian regeneration by the expression of apoptosis-related genes and TUNEL assay. Gene. 333:15–25. 2004. View Article : Google Scholar : PubMed/NCBI
17	Balsinde J, Pérez R and Balboa MA: Calcium-independent phospholipase A₂ and apoptosis. Biochim Biophys Acta. 1761:1344–1350. 2006. View Article : Google Scholar : PubMed/NCBI
18	Lawlor G, Doran PP, MacMathuna P and Murray DW: MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE₂. J Exp Clin Cancer Res. 29:812010. View Article : Google Scholar : PubMed/NCBI
19	Rasmuson A, Kock A, Fuskevåg OM, et al: Autocrine pros-taglandin E₂ signaling promotes tumor cell survival and proliferation in childhood neuroblastoma. PLoS One. 7:e293312012.
20	Huang Q, Li F, Liu X, et al: Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 17:860–866. 2011. View Article : Google Scholar : PubMed/NCBI
21	Bergers G and Hanahan D: Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 8:592–603. 2008. View Article : Google Scholar : PubMed/NCBI
22	Rini BI and Atkins MB: Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol. 10:992–1000. 2009. View Article : Google Scholar : PubMed/NCBI
23	Pàez-Ribes M, Allen E, Hudock J, et al: Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 15:220–231. 2009.PubMed/NCBI
24	Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG and Kerbel RS: Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 15:232–239. 2009. View Article : Google Scholar : PubMed/NCBI